Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
United Parcel Service
UPS
|
+$445M |
| 2 |
DexCom
DXCM
|
+$427M |
| 3 |
WIX.com
WIX
|
+$371M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$270M |
| 5 |
Advanced Micro Devices
AMD
|
+$265M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.21B |
| 2 |
Merck
MRK
|
+$535M |
| 3 |
Microchip Technology
MCHP
|
+$526M |
| 4 |
Illumina
ILMN
|
+$473M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$455M |
Sector Composition
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.42% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Vanguard FTSE Europe ETF
VGK
$26.9B
| $40.1M | 0.02% |
596,729
+57,631
| +11% | +$3.88M |
|
627
Diodes
DIOD
$2.44B
| $39.9M | 0.02% |
500,080
+293,852
| +142% | +$23.4M |
|
628
Hologic
HOLX
$14.6B
| $39.8M | 0.02% |
596,918
-310,686
| -34% | -$20.7M |
|
629
Biomea Fusion
BMEA
$109M
| $39.6M | 0.02% |
+2,627,382
| New | +$39.6M |
|
630
Levi Strauss
LEVI
$8.59B
| $39.4M | 0.02% |
1,421,107
-1,095,794
| -44% | -$30.4M |
|
631
Prudential Financial
PRU
$37.2B
| $39.3M | 0.02% |
383,998
+292,157
| +318% | +$29.9M |
|
632
Robert Half
RHI
$3.56B
| $39.1M | 0.02% |
440,029
-70,299
| -14% | -$6.25M |
|
|
ARGO
633
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $38.7M | 0.02% |
747,419
-78,675
| -10% | -$4.08M |
|
634
NetApp
NTAP
$24.7B
| $38.7M | 0.02% |
472,827
+407,070
| +619% | +$33.3M |
|
635
Western Digital
WDC
$33B
| $38.6M | 0.02% |
717,429
+169,121
| +31% | +$9.1M |
|
636
Kornit Digital
KRNT
$662M
| $38.3M | 0.02% |
307,692
-10,809
| -3% | -$1.34M |
|
637
Delek US
DK
$1.79B
| $38M | 0.02% |
1,759,278
-179,335
| -9% | -$3.88M |
|
638
Janus International
JBI
$1.4B
| $38M | 0.02% |
+2,689,173
| New | +$38M |
|
|
CYT
639
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $37.9M | 0.02% |
+1,889,833
| New | +$37.9M |
|
640
State Street
STT
$31.4B
| $37.8M | 0.02% |
459,634
+362,902
| +375% | +$29.9M |
|
641
Steven Madden
SHOO
$2.22B
| $37.7M | 0.02% |
862,264
-1,065,799
| -55% | -$46.6M |
|
642
FirstService
FSV
$9.32B
| $37.6M | 0.02% |
219,677
-8,230
| -4% | -$1.41M |
|
643
Franklin FTSE United Kingdom ETF
FLGB
$851M
| $37.6M | 0.02% |
1,518,186
+165,533
| +12% | +$4.1M |
|
644
Pfizer
PFE
$140B
| $37.5M | 0.02% |
958,276
-3,286,278
| -77% | -$129M |
|
|
DEA
645
Easterly Government Properties
DEA
$1.06B
| $37.5M | 0.02% |
711,462
-91,342
| -11% | -$4.81M |
|
646
Stride
LRN
$6.89B
| $37.5M | 0.02% |
1,165,658
-54,221
| -4% | -$1.74M |
|
647
4D Molecular Therapeutics
FDMT
$324M
| $37.1M | 0.02% |
1,539,726
+312,329
| +25% | +$7.52M |
|
|
LENZ
648
LENZ Therapeutics
LENZ
$1.19B
| $36.7M | 0.02% |
+178,715
| New | +$36.7M |
|
649
Edgewise Therapeutics
EWTX
$1.55B
| $36.7M | 0.02% |
1,789,280
-351,628
| -16% | -$7.21M |
|
650
Leidos
LDOS
$23.1B
| $36.4M | 0.02% |
360,153
-784,211
| -69% | -$79.3M |
|